Subtopic Deep Dive
Wnt Signaling in Dupuytren's Pathogenesis
Research Guide
What is Wnt Signaling in Dupuytren's Pathogenesis?
Wnt signaling in Dupuytren's pathogenesis refers to the activation of the canonical Wnt/β-catenin pathway driving myofibroblast differentiation and palmar fibrosis in Dupuytren's disease.
Studies identify genetic variants near Wnt pathway genes associated with Dupuytren's susceptibility (Dolmans et al., 2011, 234 citations). Elevated β-catenin levels in three-dimensional collagen cultures of Dupuytren's cells promote fibronectin expression and contractility, regulated by mechanical tension (Howard et al., 2003, 57 citations). Genome-wide analyses link Wnt-related loci to fibrotic gene expression in affected tissues (Ng et al., 2017, 97 citations; Forrester et al., 2013, 42 citations).
Why It Matters
Wnt pathway activation contributes to myofibroblast persistence, offering targets for anti-fibrotic therapies to prevent contracture progression. Dolmans et al. (2011) identified Wnt signaling variants in a GWAS, linking them to disease susceptibility and suggesting inhibitors like those tested in related fibromatoses. Howard et al. (2003) showed tension-regulated β-catenin elevation in Dupuytren's cells, supporting biomechanical interventions. Ng et al. (2017) expanded variants to 17 fibrosis-related loci, including Wnt, enabling precision medicine approaches. Targeting Wnt halts ECM remodeling seen in Forrester et al. (2013) exon array data.
Key Research Challenges
Genetic Variant Functional Validation
Linking GWAS hits like those in Dolmans et al. (2011) to Wnt pathway causality requires in vitro and animal models. Functional studies are limited beyond β-catenin assays in Howard et al. (2003). Translating variants to myofibroblast behavior remains incomplete (Ng et al., 2017).
Mechanical Tension-Wnt Crosstalk
Tension upregulates β-catenin in 3D cultures, but in vivo quantification in palmar fascia is lacking (Howard et al., 2003). Integrating biomechanical models with Wnt signaling needs advanced imaging. Fibrotic progression models underexplore this interaction.
Therapeutic Wnt Inhibition Safety
Wnt inhibitors risk off-target effects given pathway's role in development and homeostasis. No Dupuytren's-specific trials exist despite genetic evidence (Dolmans et al., 2011). Balancing efficacy with systemic safety draws from fibrosis analogs (Forrester et al., 2013).
Essential Papers
Wnt Signaling and Dupuytren's Disease
Guido H. Dolmans, Paul M. N. Werker, Hans Christian Hennies et al. · 2011 · New England Journal of Medicine · 234 citations
BACKGROUND: Dupuytren's disease is a benign fibromatosis of the hands and fingers that leads to flexion contractures. We hypothesized that multiple genetic and environmental factors influen...
A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in Fibrosis
Michael Ng, Dipti Thakkar, Lorraine Southam et al. · 2017 · The American Journal of Human Genetics · 97 citations
A Systematic Review and Meta-Analysis on the Strength and Consistency of the Associations between Dupuytren Disease and Diabetes Mellitus, Liver Disease, and Epilepsy
Dieuwke C. Broekstra, Henk Groen, Sanne Molenkamp et al. · 2018 · Plastic & Reconstructive Surgery · 70 citations
Background: The role of diabetes mellitus, liver disease, and epilepsy as risk factors for Dupuytren disease remains unclear. In this systematic review and meta-analysis, the strength and consisten...
Elevated levels of β-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren's disease cells are regulated by tension in vitro
Jeffrey C. Howard, Vincenzo M Varallo, Douglas C. Ross et al. · 2003 · BMC Musculoskeletal Disorders · 57 citations
Three-dimensional collagen matrix cultures of primary disease cell lines are more contractile and express a more extensive filamentous actin network than patient-matched control cultures. The eleva...
Bayesian Modelling of Dupuytren Disease by Using Gaussian Copula Graphical Models
Reza Mohammadi, Fentaw Abegaz, Edwin R. van den Heuvel et al. · 2016 · Journal of the Royal Statistical Society Series C (Applied Statistics) · 56 citations
Summary Dupuytren disease is a fibroproliferative disorder with unknown aetiology that often progresses and eventually can cause permanent contractures of the fingers affected. We provide a computa...
Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial
Jagdeep Nanchahal, Catherine Ball, Dominique Davidson et al. · 2018 · EBioMedicine · 52 citations
Association among work exposure, alcohol intake, smoking and Dupuytren's disease in a large cohort study (GAZEL)
Alexis Descatha, Matthieu Carton, Zakia Médiouni et al. · 2014 · BMJ Open · 49 citations
Objectives In view of the debate of factors in Dupuytren’s disease, we aimed to describe its relationship with certain occupational factors, alcohol intake and smoking. Setting The French GAZEL coh...
Reading Guide
Foundational Papers
Start with Dolmans et al. (2011, 234 citations) for Wnt GWAS discovery, then Howard et al. (2003, 57 citations) for β-catenin in tension-regulated cultures, establishing genetic and cellular mechanisms.
Recent Advances
Ng et al. (2017, 97 citations) expands to 17 fibrosis variants; Forrester et al. (2013, 42 citations) details ECM/Wnt expression via exon arrays.
Core Methods
GWAS for variants (Dolmans 2011), 3D collagen matrix cultures for β-catenin assays (Howard 2003), exon arrays for gene expression (Forrester 2013).
How PapersFlow Helps You Research Wnt Signaling in Dupuytren's Pathogenesis
Discover & Search
Research Agent uses searchPapers('Wnt β-catenin Dupuytren myofibroblast') to retrieve Dolmans et al. (2011), then citationGraph reveals 234 citing papers on Wnt variants. findSimilarPapers on Howard et al. (2003) uncovers tension-fibrosis links. exaSearch('Wnt signaling Dupuytren 3D culture') surfaces related fibromatosis studies.
Analyze & Verify
Analysis Agent applies readPaperContent on Dolmans et al. (2011) to extract GWAS Wnt loci, then verifyResponse with CoVe checks variant-fibrosis claims against Ng et al. (2017). runPythonAnalysis plots β-catenin levels from Howard et al. (2003) data using pandas for tension correlations. GRADE grading scores genetic evidence as high from 234-citation foundational work.
Synthesize & Write
Synthesis Agent detects gaps in Wnt therapeutic trials via contradiction flagging across Dolmans (2011) and Nanchahal (2018). Writing Agent uses latexEditText for pathway diagrams, latexSyncCitations integrates 10+ papers, and latexCompile generates a review section. exportMermaid visualizes Wnt/β-catenin to myofibroblast differentiation flowchart.
Use Cases
"Extract and plot β-catenin expression data from Dupuytren 3D culture papers"
Research Agent → searchPapers('β-catenin Dupuytren collagen culture') → Analysis Agent → readPaperContent(Howard 2003) → runPythonAnalysis(pandas plot tension vs β-catenin) → matplotlib figure of elevated levels vs controls.
"Draft LaTeX review on Wnt GWAS in Dupuytren's with citations"
Research Agent → citationGraph(Dolmans 2011) → Synthesis Agent → gap detection(therapeutics) → Writing Agent → latexEditText('Wnt section') → latexSyncCitations(10 papers) → latexCompile → PDF with synced refs.
"Find code for Wnt pathway simulations linked to Dupuytren papers"
Research Agent → searchPapers('Wnt Dupuytren simulation model') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → Python scripts for β-catenin dynamics from fibrotic models.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(50+ Wnt Dupuytren) → citationGraph → GRADE all → structured report on pathogenesis. DeepScan applies 7-step analysis to Howard et al. (2003): readPaperContent → runPythonAnalysis(tension data) → CoVe verification → myofibroblast insights. Theorizer generates hypotheses linking Dolmans (2011) variants to tension-regulated Wnt from Forrester (2013) ECM data.
Frequently Asked Questions
What defines Wnt signaling in Dupuytren's pathogenesis?
Canonical Wnt/β-catenin pathway activation drives myofibroblast differentiation and fibrosis, with elevated β-catenin in 3D cultures (Howard et al., 2003) and genetic variants identified via GWAS (Dolmans et al., 2011).
What methods study Wnt in Dupuytren's?
GWAS identifies susceptibility loci (Dolmans et al., 2011; Ng et al., 2017), 3D collagen cultures measure β-catenin/fibronectin under tension (Howard et al., 2003), and exon arrays profile ECM/Wnt genes (Forrester et al., 2013).
What are key papers on this topic?
Dolmans et al. (2011, NEJM, 234 citations) links Wnt to susceptibility; Howard et al. (2003, 57 citations) shows tension-regulated β-catenin; Ng et al. (2017, 97 citations) adds 17 fibrosis variants.
What open problems exist?
Validating GWAS variants functionally, developing Wnt inhibitors without off-target effects, and modeling in vivo tension-Wnt crosstalk lack direct studies beyond cell cultures (Dolmans 2011; Howard 2003).
Research Dupuytren's Contracture and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Wnt Signaling in Dupuytren's Pathogenesis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers